Home » Topics » BioWorld Science

BioWorld Science
RSS

BetterLife's AP-003 shows in vitro antiviral activity against SARS-CoV-2

July 16, 2021

Phase II trial evaluates combination of VIR-2218 and VIR-3434 for chronic hepatitis B

July 16, 2021

KRIBB-11 controls molecular pathways with potential for therapeutic strategy for glioblastoma

July 16, 2021

H3Mab-17 significantly reduces tumor growth in mouse model of colorectal adenocarcinoma

July 16, 2021

IL-1alpha inhibition reduces hyperinflammation in a COVID-19 murine model

July 16, 2021

Novel PIV5-based mucosal vaccine protects mice and ferrets against SARS-CoV-2 challenge

July 16, 2021

Tumor suppressor p53 is inactivated by lncRNA

July 16, 2021

First patient dosed in global phase I study of TST-005

July 16, 2021

Serum HBD2 is a marker of chronic spontaneous urticaria

July 16, 2021

Positive topline data from phase Ib study of GLPG-3667 in psoriasis

July 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...